Pharmacology

Action Mechanism of Action Reference
ANTISENSE INHIBITOR Angiopoietin like 3 (ANGPTL3) mRNA antisense inhibitor Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hyperlipoproteinemia Type II 2 D006938 ClinicalTrials
Lipodystrophy, Familial Partial 2 D052496 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298197
FDA SRS A7YG62NHZ6